154 related articles for article (PubMed ID: 1318313)
1. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system.
Medcalf RL
J Biol Chem; 1992 Jun; 267(17):12220-6. PubMed ID: 1318313
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3',5'-monophosphate.
Bergonzelli GE; Kruithof EK; Medcalf RL
Endocrinology; 1992 Sep; 131(3):1467-72. PubMed ID: 1354603
[TBL] [Abstract][Full Text] [Related]
3. Okadaic acid induction of the urokinase-type plasminogen activator gene occurs independently of cAMP-dependent protein kinase and protein kinase C and is sensitive to protein synthesis inhibition.
Nagamine Y; Ziegler A
EMBO J; 1991 Jan; 10(1):117-22. PubMed ID: 1846595
[TBL] [Abstract][Full Text] [Related]
4. Okadaic acid strongly increases gene transcription, mRNA and protein level for the urokinase receptor in human A549 cells.
Lund LR; Danø K
FEBS Lett; 1992 Feb; 298(2-3):177-81. PubMed ID: 1312023
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract][Full Text] [Related]
8. Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells.
Georg B; Riccio A; Andreasen P
Mol Cell Endocrinol; 1990 Aug; 72(2):103-10. PubMed ID: 1704320
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
Schuster WA; Medcalf RL; Kruithof EK
Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
[TBL] [Abstract][Full Text] [Related]
10. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
[TBL] [Abstract][Full Text] [Related]
11. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
Antalis TM; Reeder JA
Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
[TBL] [Abstract][Full Text] [Related]
12. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
Medcalf RL; Van den Berg E; Schleuning WD
J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression.
Costa M; Shen Y; Medcalf RL
FEBS Lett; 2000 Sep; 482(1-2):75-80. PubMed ID: 11018526
[TBL] [Abstract][Full Text] [Related]
15. Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB.
Westermarck J; Lohi J; Keski-Oja J; Kähäri VM
Cell Growth Differ; 1994 Nov; 5(11):1205-13. PubMed ID: 7848922
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.
van Hinsbergh VW; van den Berg EA; Fiers W; Dooijewaard G
Blood; 1990 May; 75(10):1991-8. PubMed ID: 2140060
[TBL] [Abstract][Full Text] [Related]
17. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
Bergonzelli GE; Kruithof EK
J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
[TBL] [Abstract][Full Text] [Related]
18. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.
Marksitzer R; Stief A; Menoud PA; Nagamine Y
J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
